Recently released rescue phase 2 clinical trials show that the humanized monoclonal antibody ziltivikimab targeting IL-6 ligand has many effects. It can reduce the ...
According to a study released Saturday by Public Health England, the Pfizer & Biontech vaccine provided 93 percent protection two weeks after inoculation against ...